[go: up one dir, main page]

GB2200633A - Antioxygen agents - Google Patents

Antioxygen agents Download PDF

Info

Publication number
GB2200633A
GB2200633A GB08801560A GB8801560A GB2200633A GB 2200633 A GB2200633 A GB 2200633A GB 08801560 A GB08801560 A GB 08801560A GB 8801560 A GB8801560 A GB 8801560A GB 2200633 A GB2200633 A GB 2200633A
Authority
GB
United Kingdom
Prior art keywords
acid
lysine
arginine
oil
fat composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB08801560A
Other versions
GB8801560D0 (en
Inventor
Jean Morelle
Eliane Lauzanne-Morelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB8801560D0 publication Critical patent/GB8801560D0/en
Publication of GB2200633A publication Critical patent/GB2200633A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00Preserving by using additives, e.g. anti-oxidants
    • C11B5/0042Preserving by using additives, e.g. anti-oxidants containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00Anti-oxidant compositions; Compositions inhibiting chemical change
    • C09K15/04Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds
    • C09K15/20Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing nitrogen and oxygen
    • C09K15/22Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing nitrogen and oxygen containing an amide or imide moiety
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)

Description

- 1. - re 7_ TITLE Antioxygen Agents-
DESCRIPTION
221- 0 0 6 3 3 The present invention relates to new anti-oxygen substances and compositions consisting of selected amino-acids or of associations of the same with basic amino-acids such as lysine and arginine. Numerous works have shown the important biological role of lipoperoxides and of the free radicals deriving from the same.
Many publications indicate that the peroxides, like free radicals, are involved in the settlement of various pathological conditions, as well as in the ageing process.
It is known that the peroxidation of lipids leads to the formation of mal onadi aldehyde which, in turn, may react with a variety of biological structures, such as phosphoaminolipids and amino-acids, for instance, and synthetizes a fluorescent pigment called lipofuscine and which is found in both aninal and vegetable aged tissues..
It has been also shown that anti-oxygen agents play an important role in human as well as in animal longevity, and that the dismutase superoxide could be considered as the most important defense agent in the organism, against the toxic effects of oxygen metabolism. (KUNIO YAGI - Lipid peroxides in biology and nedicine - Academic Press 1982), (FRIDOVICH I Adv. in enzymology 1986), (MELBORN R - COLE G - Adv. Free Radical Biology and Medicine 1985), (Cutler R - antioxidants and longevity of mammalian species - Life Sci. 1985).
A large number of publications deals with the formation of the peroxides and the means of acting against them by means of anti-oxygen agents. That is why 'the use of anti-oxygen agents in human and animal food is highly desirable both from a physiological and from an economic point of view and, in this regard. numerous substances such as tocopberol, the gallates, ascorbates and mainly the butylbydroxypanisols, or BHA, and butylbydroxytoluenes, or BHT, are presently legally used.
In our previous British patent application No. 2181647 it was shown that associations of fatty acids and basic amino-acids presented anti-oxygen properties. The present invention relates to new anti-oxygen substances, characterised by the fact that they contain certain lipoaminoacids or associations of the same with basic amino-acids such as lysine and arginine, which may be advantageously used for protection against oxidative degradation either of emulsions containing lipids,or of vegetable or animal oils and fats.
Depending on the nature of the fatty substances or of the compositions which contain the same and which must be protected against auto-oxidation, the present invention provides a number of strictly biological compositions, (anti-oxygen compounds of this kind are usually found in living organisms) which are deprived of any toxic action whatsoever and that can, moreover, be considered as nutriments. This kind of anti-oxygen agent is characterised by highly anti-oxygen properties which are somet. imes superior to those of the most active synthetic anti-oxygen agents used in legal doses for the protection of fats i.e. the above mentioned BHT and BHA, for instance.
The invention provides an antioxygen agent having the formula R 1 CH-COOH. [H N-A-(CH) -CH-COOH1 A 2 2 3 1 NH-CO-R NE 2 n wherein R represents a saturated or unsaturated hydrocarbon chain having from 4 to 32 carbon atoms, -A represents a methylene group or a group of the formula -C-NH-, R 1 11 NB is a residue such that R'-CH-COOH represents a naturally 1 NH2 occuring essential animoacid or protein, and n is 0 or 1 if R 1 represents a 2-methylthio-ethyl group or 1 otherwise.
In order to determine the anti-oxygen activity of the various biological substances or compositions subject of the present invention, various fatty compositions (oils, fats or emulsions) are submitted to U.V. radiation (252 nm), over a period of fifteen hours, at temperature of 50 to 600C, depending on the case.
For each tested fatty composition 10 g were used, placed in small Petri boxes of the same size; the irradiation in this temperature range accelerated the peroxidation process.
After irradiation, 19 of fatty composition was taken and placed in a. 100 M1 flask fitted with a stopper and a glass tube of approximately 50 cirt; 1 9 of potassium iodide and 25 ml of a mixture of 312 acetic acid/chloroform were added. The flask. fitted with its tube, was placed in a dark vessel so as to be protected from light and brought to the boiling point for exactly three minutes. The solution was cooled and then about fifty ml of water and a few drops of starch paste were added. It was titrated with a N/200 solution sod ium hyposulfite until the S 4--solution became colourless. The number of ml used to neutralise the freed iodine corresponds to the peroxide index of the non protected fatty composition indicated in the following tables by the letter A and retained as control. By comparsion with A it was easy to calulate the protection rate indicated by the letter B for the fatty compositions protected by various substances.
The results are reported in the following tables.
From this experimentation it may be concluded that:
1-) The lipoaminoacidic structures are generally weakly anti-oxygen for oils as well as for fat--,; 2-) The combination of lipoaminoacids + basic amino acids such as lysine and arginine leads to very active anti-oxygen agents but they cannot be used in fats because of their insolubility; 3-) The lipoaminoacids resulting from the acylation of methionine by saturated or unsaturated fatty chains have highly anti-oxygen properties; such structures have a particularly interesting advantage: their components are fundamental elements of living tissues. Finally, due to its biological nature, this group of anti-oxygen agents presents also nutritional properties.
Tables Nos.1 and 2 indicate the protective action of associations of lipoaminoacids with 2.5% of lysine and arginine on different vegetable oils, compared with lipoaminoacids which are not associated with basic amino-acids. The BHT (E 321) used as a reference, at 0.2%, i.e. at a higher concentration than legally admitted (0.01% or 150 ppm-according to the case).
Z - 5 41 11 v 11 Table No. 1
Sunflower Sesame Seed Alnond Tested Oil oil Oil substances A B A B A B Control oils 6.6 5.8 9.2 B H T -2 % 5.5 17 2.5 57 2.7 71 PalnitoyIkeratinic acid 4.9 26 3.0 48 3.6 61 Lysine palnitoyl keratinate 0.9 86 0.1 98 0.1 99 Palmitoylcaseinic acid 3.8 42 % 2.4 55 % 4.2 54 % Lysine palmitoylcaseinate 0.8 as % 0.1 99 0.1 99 Palmitoyl collagenic acid 5.7 14 % 3.3 43 % 3.8 59 % Lysine palmitoyl-- 1 collagenate 0.6 91 % 0.6 90 % 0.1 99 Palmitoylcystinic acid (+) 1.8 73 % 1.0 83 % 0.9 90 Lysine 1 palmitoylcystinate 0.1 99 % -0.1 99 % 0.1 99 % Butyryl-lysinic acid 5.5 17 % 4.3 26 % 8.2 11 Lysine butyryllysinate 0.7 89 % 0.5 90 % 1.5 84 Lysine 1 t-1 butyrylcystinate 0.8 84 % 0.7 88 % 1.8 so Table No. 2
Sunflower Sesame Seed Almond Tested oil oil Oil substances A B A B A B Control oils 7.5 5.2 9.2 BFIT - 2 5.0 33 3.6 31 % 2.7 71 Palmtoylkeratinic acid 4.5 40 1.0 80 % 3.6 61 Arginine palmi toylkeratinate 0.1 99 0.1 99 % 0.7 93 Palmitoylcaseinic acid 5.4 28 1.3 75 % 4.2 54 Arginine palmi toylcaseinate 0.1 99 O.i 9 9 % 0.1 99 Palmitoyl collagenic acid 6.2 17 % 2.2 58 % 3.8 59 % Arginine palmi toylcollagenate 0.3 94 0.1 99 0.6 93 Palmitoylcystinic acid (+) 2.4 68 % 0.8 85 % 0.9 so % Arginine palni toylcystinate 1.1 86 0.3 94 0.6 94 poorly soluble in oils unless heated at a temperature that may alter the same.
i 1 1 9 The following table No. 3 shows the protection provided to four vegetable oils by different lipomethionic acids, after a period of 15 hours of irradiation at 60C.
Table No. 3
Sunflower Hazelnut Sesame Almond Tested Seed Oil Oil oil oil substances A7 B A' B A B A B Control oils 13.0 20.2 6.9 15.0 B H T - 2 7.7 41% 11.0 46% 5.9 15% 7.0 53% Palmitoyl nethionic 1.9 86% 1.0 95% 0.9 87% 1.0 94% acid - 2 % Caprylyl nethionic 1.9 86% 1.0 95% 0.6 91% 1.2 92% acid - 2 % Lauroyl nethionic 1.9 86% 1.0 95% 0.8 89% 1.2 92% acid - 2 % Butyrylnethionic 2.0 85% 1.2 95% 0.8 89% 1.8 88% acid - 2 % Oleoyl- methionic 0.8 94% 0.8 96% 0.4 94% 0.7 95% acid - 2 % The following Table No. 4 shows the protection provided to three different fats by lipomethionic acids having contents of 3 %, 2 -% and I - %, in comparison with the 0. 2 % BHT and an acyleted derivative of sarcosine which is not biochemically a lipoaminoacid.
Table No. 4
Raw Refined Tested Lard tallow tan-low substances AT B A B A 13 Control fat S 31.5 3.5 14.0 B H T - 0,2 % 2.3 93 % 1.5 58 % 1.5 89 Palmitoylmethionic acid 3.2 90 1.0 72 1.6 89 - 2 % - 3.2 90 % 1.2 66 % 1.7 88 - 1 % 9.7 69 % 2.1 40 % 4.5 68 Caprylylmethionic acid 3 3.1 90 1.2 66 % 1.9 87 2 % 3.1 90 % 1.2 66 %' 2.0 86 - 1 % 5.4 83 % 1.6 55 % 4.9 65 LauroylMethionic acid - 3 3.2 90 % 1.0 72 % 1.4 90 - 2 3.2 90 % 1.1 69 % 2.0 86 6.8 78 k 2.2 37 %.5.0 65 Butyrylmethionic acid - 3 5.2 84 % 1.3 63 % 4.0 72 - 2 5.6 83 % 1.3 63 % 4.9 64 - 1 12.2 62 % 2.3 35 % 6.0 57 Oleoylmethionic acid - 3 0.1 99 % 0.0 100 % 0,9 94 - 2 0.3 98 % 0.0 100 % 0.9 94 Lauroylsarcosine::1 - 3 % 26.7 15 4.7 - 13.7 3 1 The following table reveals the weak antioxygen protection of some examples of lipoaninoacids, with regard to refined tallow, in comparison with table No. 4.
Table No. 5
Tested substances Ref ined tallow A B Control 11.0 B H T - 0.2 2.0 82 Palinitoylcollagenic acid - 2 % 7.2 35 Palinitoylcaseinic acid - 2 % 5.0 55 PalmitoyIkeratinic acid - 2 % 4.7 58 Palmitoylhydroxyprolinic acid - 2 10.5 0.5 Palmitoylcystinic acid - 2 % 9.7 1.4 Palmitoylprolinic acid - 2 % 10.5 0.5 Palnitoylphenylalanic acid 9.8 1.2 The following table shows the evolution of peroxydation eight days after the irradiation of ref ined tallow (initial figures given in table No. 4).
Table No. 6
Immediately after Tested uv irradiation 8 days later substances A B A B control 14.0 24.5 B H T - 0.2 1.5 89 1.9 93 Palmitoylnethionic acid - 3 1.6 89 1.9 93 - 2 1.7 88 2.1 91 Caprylylnethionic acid - 3 % 1.9 87 2.5 90 - 2 % 2.0 86 2.0 92 % Lauroylmethionic acid - 3 1.4 90 2.8 89 - 2 2.0 86 2.2 91 Oleoylnethionic acid - 3 % 0.8 94 95 - 2 0.8 94 95 As can be seen f rom, these tables Nos - 4 and 6, it is surprising that an unsaturated fat chain, such as oleic acid, which is easily auto- oxydisable and nethionine acyiated, provides such remarkable antioxygen properties. It is also surprising that' only the lipomethionic acids ensure good protection for vegetable as well as animal oils; this is not the case for one of the most efficient antioxygen agents, such as the BHT.
W V Table No. 7 gives the results of the comparison of the protective activity of some lipoaminoacids and their arginine and lysine derivatives on three emulsified oils. oil: 10 %, polyoxyethylenated fatty alcohol 10 %, lipoaminoacid or derivative: 5 k, water: sufficient amount to 100 %; 15 hours of irradiation at Sowc. (As water evaporates,, its content is completed to 5).
Table No. 7
Tested Sunflower Hazelnut Sesame substances A B A B A B Controls 18.0 9.0 4.4 B H T - 0.2 6.8 62 % 2.8 69 % 2.1 52 Palmitoylcollagenic acid 8.5 53 % 4.5 50 % 3.6 is Lysine palmitoyl collagenate 4.5 75 % 2.5 72 2% 2.0 55 _% Arginine paimitoyl collagenate 4.2 77 % 3.8 58 % 2.2 50 % Pal,mltoylkeratinic acid 8.2 54 % 3.7 57 % 3.7 16 Lysine palmitoylkeratinate 3.2 82 % 3.2 65 % 2.2 50 Arginine palmitoyl- 1 keratinate 3.1 83 % 3.2 65 % 2.4 45 Palmitoylcaseinic acid 7.8 57 % 3.4 62 % 3.4 33 % Lysine palmitoyl caseinate 3.5 so % 2.9 68 % 2.0 55 % Arginine palmitoyl caseinate 3.2 82 % 3.1 66 % 2.3 75 Palmitoylcystinic acid 7.0 61 % 3.2 65 % 2.8 47 Lysine palmitoyl cystinate 4.5 75 % 2.2 76 % 2.6 61 Palmitoylhydroxypro- linic, acid 10.3 43 % 6.0 ' 33 % 3.8 14 Lysine palmitoyl hydroxyprolinate 1 4.5 75 % 4.2 53 % 2.8 47 Table No. 8 shows the protective activity on emulsions containing 10 oil, by five liponethionic acids with contents from 2 to 0.2 Table No. 8
Sunflower Hazelnut Tested substances Controls 23.0 6.5 B H T - 0.2 1.9 92 % 2.9 53 Palmitoylnethionic acid 2 % 1.5 95 % 0.0 100 % caprylylnethionic acid - 2 % 0.3 99 _% 0.0 100 % Lauroylmethionic acid - 2 % 0.3 99 % 0.0 100 % Butyrylmethionic acid - 2 % 4.5 so % 0.0 100 % OleoyInethionic acid - 2 % 0.2 99 % 0.0 100 % Controls 20.5 7.8 B H T - 0.02 15.0 27 % 6.7 24 Palmitoylmethionic acid - 0.2 15.2 26 % 5.5 30 caprylylnethionic acid 0.2 14.0 32 % 5.8 26 Lauroylmethionic acid - 0.2 % 15.3 27 % 5.9 25 Butyrylnethionic acid - 0.2 % 14.8 28 5.9 25 oleoylnethionic acid - 0.2 % 14.2 30 5.5 9 W i The -invention applie s to all cosmetic, pharmaceutical, nutritional or industrial compositions comprising fats or oils of animal origin (land or sea), or of vegetable origin, or even mineral origin, which would be protected from oxydative deterioration by the incorporation of lipoaminoacidic lysine or arginine salts, or by a lipoaminoacid derived from the acylation of a fatty chain of nethionine, in conformity with thestructures hereinabove described.
The invention is more specifically interesting for it affords a protection of fats, oils and the like against oxydative alteration by substances of strictly biological nature, the structure of which is very close to that one of the living tissues; due to this similarity of structure, these substances are highly effective against endogenic or exogenic fret radicals which are largely responsible for the acceleration of the ageing process and the genesis of many diseases.

Claims (6)

  1. CLAIMS 1. An antioxygen agent having the formula
    R 1 CH-COOH. [H2 N-A- (CH 2) -CH-COOH1 1 3 1 n NH-PO-R NH2 wherein R represents a saturated or unsaturated hydrocarbon chain having from 4 to 32 carbon atoms, A represents a methylene group or a group of the formula -C-NH-, R NH is a residue such that R'-CH-COOH represents a naturally NH 2 occuring essential animoacid or protein, and n is 0 or 1 if R 1 represents a 2-methylthio-etbyl group or 1 otherwise.
  2. 2. An antioxygen agent according to claim 1 which is one of palmitoylmethionic acid, caprylylmethionic acid, lauroylinethionic acid, butyrylmethionic acid, oleoylmethionic acid, lysine palmitoylkeratinic acid, arginine palmitoylkeratinic acid, lysine palmitoylcaseinate, arginine palmitoylcaseinate, lysine palmitoylcollagenate, arginine palmitoylcollagenate, lysine palmitoylcystinate, arginine palmitoylcystinate, lysine butyryllysinate, lysine butyryleystinate, and lysine palmitoylhydroxyprolinate.
    - is -
  3. 3. An oil or fat composition containing an antioxygen agent according to claim I or claim 2 in an amount effective to protect the oilor fat against oxidative degradation.
    1 t
  4. 4. A cosmetic substance containing an oil or fat composition according to claim 3.
  5. 5. A pharmaceutical substance containing an oil or fat composition according to claim 3.
  6. 6. A nutriment containing an oil or fat composition according to claim 3.
    - -... 1 1 --- -- -- ---- --- C _ TZ---. AR"11 Widh T;ihnrn- London WC1R 4TP. Purther copies may be obtained frOM MACP8tent, C)2ice
GB08801560A 1987-01-26 1988-01-25 Antioxygen agents Withdrawn GB2200633A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8700882A FR2609998B1 (en) 1987-01-26 1987-01-26 NOVEL ANTIOXIDANT SUBSTANCES DERIVED FROM AMINO ACIDS

Publications (2)

Publication Number Publication Date
GB8801560D0 GB8801560D0 (en) 1988-02-24
GB2200633A true GB2200633A (en) 1988-08-10

Family

ID=9347272

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08801560A Withdrawn GB2200633A (en) 1987-01-26 1988-01-25 Antioxygen agents

Country Status (4)

Country Link
JP (1) JPS63218649A (en)
DE (1) DE3802216A1 (en)
FR (1) FR2609998B1 (en)
GB (1) GB2200633A (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2654107A1 (en) * 1989-11-03 1991-05-10 Morelle Jean Lipoamino acids with non-peroxidisable unsaturated fatty chains
EP0478628A1 (en) * 1989-06-06 1992-04-08 Centre National De La Recherche Scientifique Pyrrol derivates, their preparation and their use as interceptors of activated dioxygen
FR2747309A1 (en) * 1996-04-16 1997-10-17 Morelle Jean Compositions for treating burns and wounds with antimicrobial, anti-free radical and regenerating activity
WO2000021925A1 (en) * 1998-10-09 2000-04-20 Ajinomoto Co., Inc. Cysteine derivatives
US6492302B1 (en) * 1998-06-17 2002-12-10 Jean Morelle Compositions for the protection of plants against the stress of oxidation
US20150064326A1 (en) * 2012-03-30 2015-03-05 Givaudan S.A. N-Acylated Methionine Derivatives as food Flavouring Compounds
US20150064327A1 (en) * 2012-03-30 2015-03-05 Givaudan S.A. N-Acyl Proline Derivatives as Food Flavouring Compounds
US10201175B2 (en) 2012-03-30 2019-02-12 Givaudan Sa N-acylated 1-aminocycloalkyl carboxylic acids as food flavouring compounds
US10537127B2 (en) 2013-10-02 2020-01-21 Givaudan S.A. Organic compounds
US10582715B2 (en) 2012-03-30 2020-03-10 Givaudan Sa Powder flavour composition
US10645955B2 (en) 2012-03-30 2020-05-12 Givaudan Sa N-acyl derivatives of gamma amino-butyric acid and beta alanine as food flavouring compounds
US10674755B2 (en) 2013-10-02 2020-06-09 Givaudan S.A. Organic Compounds
US10834950B2 (en) 2013-10-02 2020-11-17 Givaudan S.A. Organic compounds
US10836712B2 (en) 2012-03-30 2020-11-17 Givaudan S.A. Organic compounds
US10834943B2 (en) 2013-10-02 2020-11-17 Givaudan S.A. Organic compounds having taste-modifying properties
US10834951B2 (en) 2013-10-02 2020-11-17 Givaudan S.A. Organic compounds
US10856563B2 (en) 2012-03-30 2020-12-08 Givaudan S.A. N-acyl-amino acid derivatives for improvement of the flavor profile of edible compositions
US10975018B2 (en) 2013-10-02 2021-04-13 Givaudan Sa Organic compounds
US11122826B2 (en) 2013-10-02 2021-09-21 Givaudan Sa Organic compounds
US11834393B2 (en) 2013-10-02 2023-12-05 Givaudan Sa Organic compounds having taste-modifying properties

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03178913A (en) * 1989-12-06 1991-08-02 Shiseido Co Ltd Skin external agent
FR2697159B1 (en) * 1992-10-22 1995-01-13 Oreal Cosmetic or dermo-pharmaceutical composition containing in combination a lauroylmethionate of a basic amino acid and at least one polyphenol.
WO2002055073A1 (en) * 2001-01-05 2002-07-18 Kyowa Kakko Kogyo Co., Ltd. Preventives for arthritis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132126C (en) * 1966-10-13
JPS52156787A (en) * 1976-06-23 1977-12-27 Shiseido Co Ltd Oil-in-water type emulsified composition
JPS5352631A (en) * 1976-10-22 1978-05-13 Kouichi Ogawa Cosmetics
FR2422400A1 (en) * 1978-04-13 1979-11-09 Morelle Jean Compsns. for treating human lice - contg. an aminoacid acylated with a fatty acid
JPS5919596B2 (en) * 1980-02-13 1984-05-07 川研フアインケミカル株式会社 New transparent solid cleaning agent
JPS5939818A (en) * 1982-08-31 1984-03-05 Lion Corp Hair cosmetic
FR2587900B1 (en) * 1985-10-01 1988-10-07 Morelle Jean BASIC FATTY-AMINO ACID ASSOCIATIONS WITH EMOLLIENT, EMULSIFIING AND ANTIOXIDANT PROPERTIES FOR COSMETICS, DERMATOLOGY AND FOOD

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
CA 66 (7):29058Y *
CA 76 (10):49827H *
CA 76 (18):103751U *
CA 77 (25):163250K *
CA 93 (21):199583R *
CA 93 (23):219595B *
CA 99 (9):69318W *
CHEMICAL ABSTRACTS *

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0478628A1 (en) * 1989-06-06 1992-04-08 Centre National De La Recherche Scientifique Pyrrol derivates, their preparation and their use as interceptors of activated dioxygen
FR2654107A1 (en) * 1989-11-03 1991-05-10 Morelle Jean Lipoamino acids with non-peroxidisable unsaturated fatty chains
FR2747309A1 (en) * 1996-04-16 1997-10-17 Morelle Jean Compositions for treating burns and wounds with antimicrobial, anti-free radical and regenerating activity
US6492302B1 (en) * 1998-06-17 2002-12-10 Jean Morelle Compositions for the protection of plants against the stress of oxidation
WO2000021925A1 (en) * 1998-10-09 2000-04-20 Ajinomoto Co., Inc. Cysteine derivatives
US6602492B2 (en) 1998-10-09 2003-08-05 Ajinomoto Co., Inc. Cysteine derivatives
US6703031B1 (en) 1998-10-09 2004-03-09 Ajinomoto Co., Inc. Cysteine derivatives
CN100408560C (en) * 1998-10-09 2008-08-06 味之素株式会社 Cysteine derivatives
US10913922B2 (en) 2012-03-30 2021-02-09 Givaudan S.A. N-acylated methionine derivatives as food flavoring compounds
US20150064326A1 (en) * 2012-03-30 2015-03-05 Givaudan S.A. N-Acylated Methionine Derivatives as food Flavouring Compounds
US10201175B2 (en) 2012-03-30 2019-02-12 Givaudan Sa N-acylated 1-aminocycloalkyl carboxylic acids as food flavouring compounds
US11832638B2 (en) 2012-03-30 2023-12-05 Givaudan Sa N-acyl derivatives of gamma amino-butyric acid and beta alanine as food flavouring compounds
US10582715B2 (en) 2012-03-30 2020-03-10 Givaudan Sa Powder flavour composition
US10645955B2 (en) 2012-03-30 2020-05-12 Givaudan Sa N-acyl derivatives of gamma amino-butyric acid and beta alanine as food flavouring compounds
US11524933B2 (en) 2012-03-30 2022-12-13 Givaudan Sa In or relating to organic compounds
US10711230B2 (en) * 2012-03-30 2020-07-14 Givaudan Sa N-acyl proline derivatives as food flavoring compounds
US11492326B2 (en) 2012-03-30 2022-11-08 Givaudan Sa Organic compounds
US10836712B2 (en) 2012-03-30 2020-11-17 Givaudan S.A. Organic compounds
US11091429B2 (en) 2012-03-30 2021-08-17 Givaudan Sa Organic compounds
US20150064327A1 (en) * 2012-03-30 2015-03-05 Givaudan S.A. N-Acyl Proline Derivatives as Food Flavouring Compounds
US10856563B2 (en) 2012-03-30 2020-12-08 Givaudan S.A. N-acyl-amino acid derivatives for improvement of the flavor profile of edible compositions
US10834951B2 (en) 2013-10-02 2020-11-17 Givaudan S.A. Organic compounds
US10975018B2 (en) 2013-10-02 2021-04-13 Givaudan Sa Organic compounds
US10834943B2 (en) 2013-10-02 2020-11-17 Givaudan S.A. Organic compounds having taste-modifying properties
US11122826B2 (en) 2013-10-02 2021-09-21 Givaudan Sa Organic compounds
US10834950B2 (en) 2013-10-02 2020-11-17 Givaudan S.A. Organic compounds
US10674755B2 (en) 2013-10-02 2020-06-09 Givaudan S.A. Organic Compounds
US11834393B2 (en) 2013-10-02 2023-12-05 Givaudan Sa Organic compounds having taste-modifying properties
US10537127B2 (en) 2013-10-02 2020-01-21 Givaudan S.A. Organic compounds

Also Published As

Publication number Publication date
FR2609998A1 (en) 1988-07-29
DE3802216A1 (en) 1988-08-04
JPS63218649A (en) 1988-09-12
GB8801560D0 (en) 1988-02-24
DE3802216C2 (en) 1991-06-20
FR2609998B1 (en) 1994-04-15

Similar Documents

Publication Publication Date Title
GB2200633A (en) Antioxygen agents
DE69225631T2 (en) Acylamino acid compounds and process for their preparation
US5431924A (en) Anti-inflammatory composition derived from emu oil
Deans et al. Promotional effects of plant volatile oils on the polyunsaturated fatty acid status during aging
WO1994024984A3 (en) Anti-inflammatory compositions containing eicosapentaenoic acid bearing monogalactosyldiacylglycerol and methods relating thereto
EP0060553A1 (en) Preparation for treating outer skin wounds and process for manufacturing said preparation
Werman et al. Oxidative stability of avocado oil
DE69332776T2 (en) ANTIOXIDANT
DE3633453A1 (en) COMPOSITIONS BASED ON LYSINE AND ARGININE SALTS
DE69024321T2 (en) Protection against oxidation of a food, a cosmetic product or a pharmaceutical product
EP0444033A1 (en) Topical cosmetic and pharmaceutical preparation
SU1286204A1 (en) Agent for fat base of cosmetic articles
EP0339382B1 (en) Process for deodorizing mixtures of fatty acid esters
GB2202146A (en) Skin-regenerating cosmetic composition
DE69809743T2 (en) WAXES ENRICHED IN OMEGA-3 UNSATURATED FATTY ACIDS, THEIR PRODUCTION AND USE
Ogasawara et al. Effects of disalicylidenepropandiamine and near far-red light on 14CO2-fixation in Chlorella cells
DE3809225A1 (en) MEDICINAL PRODUCTS SUITABLE FOR PREVENTING OR RELATIVELY TREATING DISEASES OF THE HEART / CIRCULAR SYSTEM
KR920010246B1 (en) Cosmetic biological compositions for inhibiting active free radicals and preparation method thereof
EP0005121B1 (en) Process for stabilisation of 4-methyl-5-(2'-chlorethyl)-thiazol
GB2150588A (en) Shampoo for promoting growth of hair
SU1713555A1 (en) Lotion for caring fatty skin of the face
DE3049123A1 (en) FATTY ACID ESTER OF 4-ISOPROPYLTROPOLON AND SKIN-BEAUTIFULING, COSMETIC AGENT
YAMAMOTO STUDIES ON LIPASE I. ON THE ACTIVATION OF PANCREAS LIPASE
US7078545B1 (en) Raspberry amido amines and betaines as a delivery system for natural antioxidants
DE3422496A1 (en) Disinfectants for the skin

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)